Cargando…

Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease

BACKGROUND: Right ventricular dysfunction after CABG is associated with poor peri- and postoperative outcomes. We aimed to identify clinical and experimental predictors for preoperative inapparent right ventricular dysfunction and therefore hypothesized that reduced myofilament force development as...

Descripción completa

Detalles Bibliográficos
Autores principales: Bening, C., Sales, V. L., Alhussini, K., Radakovic, D., Benitez, R. Cris, Madrahimov, N., Keller, D., Leyh, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934411/
https://www.ncbi.nlm.nih.gov/pubmed/33663396
http://dx.doi.org/10.1186/s12872-021-01926-6
_version_ 1783660809205841920
author Bening, C.
Sales, V. L.
Alhussini, K.
Radakovic, D.
Benitez, R. Cris
Madrahimov, N.
Keller, D.
Leyh, R.
author_facet Bening, C.
Sales, V. L.
Alhussini, K.
Radakovic, D.
Benitez, R. Cris
Madrahimov, N.
Keller, D.
Leyh, R.
author_sort Bening, C.
collection PubMed
description BACKGROUND: Right ventricular dysfunction after CABG is associated with poor peri- and postoperative outcomes. We aimed to identify clinical and experimental predictors for preoperative inapparent right ventricular dysfunction and therefore hypothesized that reduced myofilament force development as well as altered levels of biomarkers might predict inapparent right ventricular dysfunction. METHODS: From 08/2016 to 02/2018, 218 patients scheduled for CABG were divided into two groups (TAPSE ≥ 20 mm, n = 178; TAPSE < 20 mm, n = 40). Baseline serum samples for biomarkers (Galectin, TGFß1, N Acyl-SDMA, Arginine, ADMA and Pentraxin-3), clinical laboratory and transthoracic echocardiographic parameters were evaluated. To examine the myocardial apparatus of the right ventricle intraoperative right auricular tissue was harvested for stepwise skinned fiber force measurements. RESULTS: Patients with TAPSE < 20 mm had a higher incidence of DM (55 vs. 34%, p = 0.018), preoperative AFib (43 vs. 16%, p < 0.001), reduced GFR (67 ± 18 vs. 77 ± 24 ml/min/1.73 m(2), p = 0.013), larger LA area (22 ± 6 vs. 20 ± 5 cm(2), p = 0.005) and reduced LVEF (50 vs. 55%, p = 0.008). Furthermore, higher serum ADMA (0.70 ± 0.13 vs. 0.65 ± 0.15 µmol/l, p = 0.046) and higher serum Pentraxin-3 levels (3371 ± 1068 vs. 2681 ± 1353 pg/dl, p = 0.004) were observed in these patients. Skinned fiber force measurements showed significant lower values at almost every step of calcium concentration (pCa 4.52 to pCa 5.5, p < 0.01 and pCa 5.75–6.0, p < 0.05). Multivariable analysis revealed DM (OR 2.53, CI 1.12–5.73, Euro Score II (OR 1.34, CI 1.02–1.78), preoperative AF (OR 4.86, CI 2.06–11.47), GFR (OR 7.72, CI 1.87–31.96), albumin (OR 1.56, CI 0.52–2.60), Pentraxin-3 (OR 19.68, CI 14.13–25.24), depressed LVEF (OR 8.61, CI 6.37–10.86), lower force values: (pCa 5.4; OR 2.34, CI 0.40–4.29 and pCa 5.2; OR 2.00, CI 0.39–3.60) as predictors for clinical inapparent right heart dysfunction. CONCLUSIONS: These preliminary data showed that inapparent right heart dysfunction in CAD is already associated with reduced force development of the contractile apparatus.
format Online
Article
Text
id pubmed-7934411
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79344112021-03-08 Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease Bening, C. Sales, V. L. Alhussini, K. Radakovic, D. Benitez, R. Cris Madrahimov, N. Keller, D. Leyh, R. BMC Cardiovasc Disord Research Article BACKGROUND: Right ventricular dysfunction after CABG is associated with poor peri- and postoperative outcomes. We aimed to identify clinical and experimental predictors for preoperative inapparent right ventricular dysfunction and therefore hypothesized that reduced myofilament force development as well as altered levels of biomarkers might predict inapparent right ventricular dysfunction. METHODS: From 08/2016 to 02/2018, 218 patients scheduled for CABG were divided into two groups (TAPSE ≥ 20 mm, n = 178; TAPSE < 20 mm, n = 40). Baseline serum samples for biomarkers (Galectin, TGFß1, N Acyl-SDMA, Arginine, ADMA and Pentraxin-3), clinical laboratory and transthoracic echocardiographic parameters were evaluated. To examine the myocardial apparatus of the right ventricle intraoperative right auricular tissue was harvested for stepwise skinned fiber force measurements. RESULTS: Patients with TAPSE < 20 mm had a higher incidence of DM (55 vs. 34%, p = 0.018), preoperative AFib (43 vs. 16%, p < 0.001), reduced GFR (67 ± 18 vs. 77 ± 24 ml/min/1.73 m(2), p = 0.013), larger LA area (22 ± 6 vs. 20 ± 5 cm(2), p = 0.005) and reduced LVEF (50 vs. 55%, p = 0.008). Furthermore, higher serum ADMA (0.70 ± 0.13 vs. 0.65 ± 0.15 µmol/l, p = 0.046) and higher serum Pentraxin-3 levels (3371 ± 1068 vs. 2681 ± 1353 pg/dl, p = 0.004) were observed in these patients. Skinned fiber force measurements showed significant lower values at almost every step of calcium concentration (pCa 4.52 to pCa 5.5, p < 0.01 and pCa 5.75–6.0, p < 0.05). Multivariable analysis revealed DM (OR 2.53, CI 1.12–5.73, Euro Score II (OR 1.34, CI 1.02–1.78), preoperative AF (OR 4.86, CI 2.06–11.47), GFR (OR 7.72, CI 1.87–31.96), albumin (OR 1.56, CI 0.52–2.60), Pentraxin-3 (OR 19.68, CI 14.13–25.24), depressed LVEF (OR 8.61, CI 6.37–10.86), lower force values: (pCa 5.4; OR 2.34, CI 0.40–4.29 and pCa 5.2; OR 2.00, CI 0.39–3.60) as predictors for clinical inapparent right heart dysfunction. CONCLUSIONS: These preliminary data showed that inapparent right heart dysfunction in CAD is already associated with reduced force development of the contractile apparatus. BioMed Central 2021-03-05 /pmc/articles/PMC7934411/ /pubmed/33663396 http://dx.doi.org/10.1186/s12872-021-01926-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Bening, C.
Sales, V. L.
Alhussini, K.
Radakovic, D.
Benitez, R. Cris
Madrahimov, N.
Keller, D.
Leyh, R.
Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease
title Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease
title_full Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease
title_fullStr Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease
title_full_unstemmed Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease
title_short Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease
title_sort clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934411/
https://www.ncbi.nlm.nih.gov/pubmed/33663396
http://dx.doi.org/10.1186/s12872-021-01926-6
work_keys_str_mv AT beningc clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease
AT salesvl clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease
AT alhussinik clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease
AT radakovicd clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease
AT benitezrcris clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease
AT madrahimovn clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease
AT kellerd clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease
AT leyhr clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease